HUP0301506A2 - Gyógyászati készítmények nedves hámfelületek fájdalmas, gyulladásos vagy fekélyes állapotai, így például nyálkahártyagyulladás, szájgyulladás és behcet-tünetcsoport kezelésére - Google Patents

Gyógyászati készítmények nedves hámfelületek fájdalmas, gyulladásos vagy fekélyes állapotai, így például nyálkahártyagyulladás, szájgyulladás és behcet-tünetcsoport kezelésére

Info

Publication number
HUP0301506A2
HUP0301506A2 HU0301506A HUP0301506A HUP0301506A2 HU P0301506 A2 HUP0301506 A2 HU P0301506A2 HU 0301506 A HU0301506 A HU 0301506A HU P0301506 A HUP0301506 A HU P0301506A HU P0301506 A2 HUP0301506 A2 HU P0301506A2
Authority
HU
Hungary
Prior art keywords
mucositis
behcet
stomatitis
painful
syndrome
Prior art date
Application number
HU0301506A
Other languages
English (en)
Inventor
Marco Mastrodonato
Original Assignee
Sinclair Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Limited filed Critical Sinclair Pharmaceuticals Limited
Priority claimed from PCT/EP2001/008303 external-priority patent/WO2002009637A2/en
Publication of HUP0301506A2 publication Critical patent/HUP0301506A2/hu
Publication of HUP0301506A3 publication Critical patent/HUP0301506A3/hu
Publication of HU228669B1 publication Critical patent/HU228669B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/04—Nickel compounds
    • C07F15/045—Nickel compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/06—Cobalt compounds
    • C07F15/065—Cobalt compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F10/00—Homopolymers and copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F110/00—Homopolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F110/02—Ethene

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány olyan gyógyászati készítményekre vonatkozik, amelyekhatásos komponensekként hatékony adagokban hialuronsavat,glicirretinsavat és polivinilpirolidont tartalmaznak toxikusadagolásra célszerű segédanyagokkal és adjuvánsok által alkotottkeverékben. Ezek a készítmények kiegészítőleg viszkozitást növelőszereket, nedvesítő, stabilizáló, tartósító szereket, ízesítőszereket, illatanyagokat, édesítő szereket és társoldószereket istartalmazhatnak. Továbbá kombinációban is alkalmazhatók olyan hatásoskomponensekkel, amelyek kiegészítő vagy bármilyen más hasznosaktivitással rendelkeznek. Ó
HU0301506A 2000-07-28 2001-07-18 Pharmaceutical compositions for the treatment of painful, inflammatory and ulcerative conditions of moist epithelial surfaces such as mucositis, stomatitis and behcet's syndrome HU228669B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI001737A IT1318653B1 (it) 2000-07-28 2000-07-28 Leganti tridentati e loro complessi con metalli di transizione.
PCT/EP2001/008303 WO2002009637A2 (en) 2000-07-28 2001-07-18 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome

Publications (3)

Publication Number Publication Date
HUP0301506A2 true HUP0301506A2 (hu) 2003-11-28
HUP0301506A3 HUP0301506A3 (en) 2004-03-01
HU228669B1 HU228669B1 (en) 2013-05-28

Family

ID=11445594

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301506A HU228669B1 (en) 2000-07-28 2001-07-18 Pharmaceutical compositions for the treatment of painful, inflammatory and ulcerative conditions of moist epithelial surfaces such as mucositis, stomatitis and behcet's syndrome

Country Status (4)

Country Link
AU (1) AU2001293704A1 (hu)
HU (1) HU228669B1 (hu)
IT (1) IT1318653B1 (hu)
WO (1) WO2002010133A1 (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0311091D0 (en) 2003-05-14 2003-06-18 Bp Chem Int Ltd Process
US20050187418A1 (en) 2004-02-19 2005-08-25 Small Brooke L. Olefin oligomerization
US7384886B2 (en) 2004-02-20 2008-06-10 Chevron Phillips Chemical Company Lp Methods of preparation of an olefin oligomerization catalyst
US9550841B2 (en) 2004-02-20 2017-01-24 Chevron Phillips Chemical Company Lp Methods of preparation of an olefin oligomerization catalyst
US20050187098A1 (en) 2004-02-20 2005-08-25 Knudsen Ronald D. Methods of preparation of an olefin oligomerization catalyst
US7727926B2 (en) 2005-07-21 2010-06-01 Chevron Phillips Chemical Company Lp Diimine metal complexes, methods of synthesis, and method of using in oligomerization and polymerization
US7271121B2 (en) 2005-07-21 2007-09-18 Chevron Phillips Chemical Company Lp Diimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization
US7268096B2 (en) 2005-07-21 2007-09-11 Chevron Phillips Chemical Company Lp Diimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization
US9394325B2 (en) * 2011-08-19 2016-07-19 The Trustees Of Princeton University Enantiopure base-metal catalysts for asymmetric catalysis and bis(imino)pyridine iron alkyl complexes for catalysis
ITMI20111651A1 (it) 2011-09-14 2013-03-15 Polimeri Europa Spa Complesso bis-immino piridinico di lantanidi, sistema catalitico comprendente detto complesso bis-immino piridinico e procedimento per la (co)polimerizzazione di dieni coniugati
US9586872B2 (en) 2011-12-30 2017-03-07 Chevron Phillips Chemical Company Lp Olefin oligomerization methods
JP6396911B2 (ja) * 2012-10-15 2018-09-26 ナノセレクト バイオメディカル， インコーポレイテッド 粒子を選別するためのシステム、装置、および、方法
ITMI20122206A1 (it) 2012-12-20 2014-06-21 Versalis Spa Procedimento per la preparazione di (co)polimeri di dieni coniugati in presenza di un sistema catalitico comprendente un complesso bis-immino-piridinico di cobalto
US9944661B2 (en) 2016-08-09 2018-04-17 Chevron Phillips Chemical Company Lp Olefin hydroboration
PT110157B (pt) * 2017-06-21 2021-01-28 Instituto Superior Técnico Complexos tridentados iminopirrolilo níquel e sua utilização como catalisadores na reação de polimerização de etileno a polietileno hiper-ramificado

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129929A0 (en) * 1996-12-17 2000-02-29 Du Pont Polymerization of ethylene with specific iron or cobalt complexes novel pyridinebis (imines) and novel complexes of pyridinebis(imines) with iron and cobalt
PL198619B1 (pl) * 1997-09-05 2008-07-31 Bp Chem Int Ltd Sposób (ko)polimeryzacji etylenu z jedną lub większą liczbą 1-olefin w obecności gazowego wodoru oraz katalizatory (ko)polimeryzacji etylenu z jedną lub większą liczbą 1-olefin w obecności gazowego wodoru
WO1999065951A1 (fr) * 1998-06-16 1999-12-23 Mitsui Chemicals, Inc. Catalyseur pour polymerisation d'olefine et procede de polymerisation de cette olefine
ATE275587T1 (de) * 1998-11-30 2004-09-15 Bp Chem Int Ltd Polymerisationsverfahren

Also Published As

Publication number Publication date
WO2002010133A1 (en) 2002-02-07
AU2001293704A1 (en) 2002-02-13
ITMI20001737A0 (it) 2000-07-28
HU228669B1 (en) 2013-05-28
HUP0301506A3 (en) 2004-03-01
IT1318653B1 (it) 2003-08-27
ITMI20001737A1 (it) 2002-01-28

Similar Documents

Publication Publication Date Title
NO20030411L (no) Farmasöytiske sammensetninger for behandlingen av smertefulle, inflammatoriske og ulceröse tilstander av fuktige epiteloverflater slik sommukositt, stomatitt og Behcets syndrom
HUP0301506A2 (hu) Gyógyászati készítmények nedves hámfelületek fájdalmas, gyulladásos vagy fekélyes állapotai, így például nyálkahártyagyulladás, szájgyulladás és behcet-tünetcsoport kezelésére
ITBO20050388A1 (it) Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
WO2021207409A3 (en) Small molecule inhibitors of sars-cov-2 viral replication and uses thereof
AR035927A1 (es) Compuesto de lactama (n)-((s)-2-hidroxi-3-metilbutiril)-1-(l-alaninil)-(s)-1-amino-3-metil-4,5,6,7-tetrahidro-2h-3-benzazepin-2-ona , composicion farmaceutica que lo comprende, procedimiento para la inhibicion de la liberacion de peptido b-amiloide y/o su sintesis que lo emplea y su uso para la fabr
AR013506A1 (es) Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida
BR0108435A (pt) Formulação e uso de entecavir de baixa dose
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BR9911072A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépicos e/ou agentes promotores da cura de feridas no trato respiratório inferior
ES2195866T3 (es) Composiciones acidas multiusos.
ATE364595T1 (de) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
ATE213626T1 (de) Feste, therapeutische oder hygienische, mucoadhäsive zusammensetzung zur verabreichung durch auftragen auf der mund-schleimhaut oder der nasen-schleimhaut
AR039388A1 (es) Formulaciones liquidas de baja dosis de entecavir y uso
DE69928806D1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
DE69403063D1 (de) Gegen viren wirksame naphtochinon-verbindungen, zusammensetzungen und deren verwendungen
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
ATE309803T1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
KR910005886A (ko) 안정화 백혈구 인터페론
HUP0401940A2 (hu) Diabetikus neuropátia esetében alkalmazható gyógyszerkészítmény
SE0203817D0 (sv) New composition
BR0213463A (pt) Composições farmacêuticas contendo macrólidos
US20080293804A1 (en) Pharmaceutical Nasal Spray Formulation of Acetaminophen (paracetamol)
ATE284696T1 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten
BR0307196A (pt) Idraparinux (sanorg 34006) para tratamento e profilaxia secundária de eventos tromboembólicos venosos em pacientes com trombose venosa profunda

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: ALLIANCE PHARMACEUTICALS LIMITED, GB

Free format text: FORMER OWNER(S): SINCLAIR PHARMACEUTICALS LIMITED, GB